Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia
PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
January 31, 2004
Study Completion Date
August 31, 2007
Conditions
Leukemia
Interventions
DRUG
imatinib mesylate
PROCEDURE
adjuvant therapy
Trial Locations (2)
91010-3000
City of Hope Comprehensive Cancer Center, Duarte
98109-1024
Fred Hutchinson Cancer Research Center, Seattle
All Listed Sponsors
lead
Fred Hutchinson Cancer Center
OTHER
NCT00244829 - Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia | Biotech Hunter | Biotech Hunter